Skip to content 
AMM 287: Baby Botox: Age Prevention Trend Among Youth Explored
December 07, 2024
This episode delves into the latest developments in regenerative aesthetics as Galderma celebrates the 25th anniversary of Sculptra®, a proven regenerative biostimulator. Listeners will learn about Sculptra’s journey from treating facial wasting in AIDS patients to becoming a versatile skin rejuvenation solution worldwide, now available in China. The episode highlights recent studies showcasing Sculptra’s effectiveness in stimulating collagen and elastin, essential for maintaining skin’s structural integrity, and discusses Galderma’s ongoing research efforts in the field.
Quick Takes
- Galderma celebrates Sculptra’s 25th anniversary
- Sculptra approved for use in China, expanding its market reach
- Latest studies show Sculptra’s ability to stimulate collagen and elastin for skin rejuvenation
Episode Transcript
Today, on the 7th of December, let’s dive into some exciting news in the world of regenerative aesthetics. Galderma, a leader in the dermatology field, is celebrating a milestone for Sculptra®, marking its 25th year since approval. This product is a proven regenerative biostimulator utilizing a unique poly-L-lactic acid formulation that works with your body’s natural processes to rejuvenate the skin. Originally launched to address facial wasting in AIDS patients, Sculptra has since transformed into a versatile treatment helping millions across over 40 countries achieve healthier, more youthful skin.
Just recently, Sculptra received approval for use in China, one of the fastest-growing markets in aesthetics. This expansion strengthens Galderma’s global presence, making it accessible to even more individuals seeking innovative, long-lasting solutions for skin rejuvenation. The latest studies, highlighted at the American Society for Dermatologic Surgery Annual Meeting, underscore its ability to stimulate components like collagen and elastin, vital for skin’s structural integrity.
With its ongoing research, Galderma aims to continually meet evolving patient needs and maintain its position as a pioneer in regenerative aesthetics【4:0†source】.
